These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10895331)

  • 21. Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Lestingi TM; Hooberman AL
    Hematol Oncol Clin North Am; 1993 Feb; 7(1):161-75. PubMed ID: 8449857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD25 Expression in B Lymphoblastic Leukemia/Lymphoma Predicts t(9;22)(q34;q11)/Philadelphia Chromosome Translocation (Ph) and Is Associated With Residual Disease in Ph-Negative Patients.
    Chen P; Chu A; Zia H; Koduru P; Collins R; Winick N; Fuda F; Chen W
    Am J Clin Pathol; 2016 Nov; 146(5):632-638. PubMed ID: 28430957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequency and prognostic significance of additional cytogenetic abnormalities to the Philadelphia chromosome in young and older adults with acute lymphoblastic leukemia.
    Motlló C; Ribera JM; Morgades M; Granada I; Montesinos P; Mercadal S; González-Campos J; Moreno MJ; Barba P; Cervera M; Barrios M; Novo A; Bernal T; Hernández-Rivas JM; Abella E; Amigo ML; Tormo M; Martino R; Lavilla E; Bergua J; Serrano A; García-Belmonte D; Guàrdia R; Grau J; Feliu E;
    Leuk Lymphoma; 2018 Jan; 59(1):146-154. PubMed ID: 28554259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Philadelphia chromosome-positive mixed phenotype acute leukemia in the imatinib era.
    Shimizu H; Yokohama A; Hatsumi N; Takada S; Handa H; Sakura T; Nojima Y
    Eur J Haematol; 2014 Oct; 93(4):297-301. PubMed ID: 24750307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does Post-Transplant Maintenance Therapy With Tyrosine Kinase Inhibitors Improve Outcomes of Patients With High-Risk Philadelphia Chromosome-Positive Leukemia?
    DeFilipp Z; Langston AA; Chen Z; Zhang C; Arellano ML; El Rassi F; Flowers CR; Kota VK; Al-Kadhimi Z; Veldman R; Jillella AP; Lonial S; Waller EK; Khoury HJ
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16(8):466-471.e1. PubMed ID: 27297665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The importance of cytogenetic studies in adult acute lymphocytic leukemia.
    Walters R; Kantarjian HM; Keating MJ; Estey EH; Trujillo J; Cork A; McCredie KB; Freireich EJ
    Am J Med; 1990 Nov; 89(5):579-87. PubMed ID: 2239977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Secondary cytogenetic aberrations in childhood Philadelphia chromosome positive acute lymphoblastic leukemia are nonrandom and may be associated with outcome.
    Heerema NA; Harbott J; Galimberti S; Camitta BM; Gaynon PS; Janka-Schaub G; Kamps W; Basso G; Pui CH; Schrappe M; Auclerc MF; Carroll AJ; Conter V; Harrison CJ; Pullen J; Raimondi SC; Richards S; Riehm H; Sather HN; Shuster JJ; Silverman LB; Valsecchi MG; Aricò M; ; ; ; ; ; ; ; ; ; ;
    Leukemia; 2004 Apr; 18(4):693-702. PubMed ID: 15044926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High hyperdiploidy among adolescents and adults with acute lymphoblastic leukaemia (ALL): cytogenetic features, clinical characteristics and outcome.
    Chilton L; Buck G; Harrison CJ; Ketterling RP; Rowe JM; Tallman MS; Goldstone AH; Fielding AK; Moorman AV
    Leukemia; 2014 Jul; 28(7):1511-8. PubMed ID: 24352198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical study of Philadelphia chromosome-positive adult acute lymphoblastic leukemia].
    Zhang YF; Chen ZM; Lou JY; Ni WM; Wang YG; Meng HT; Tong HY; Qian WB; Jin J
    Zhonghua Xue Ye Xue Za Zhi; 2011 Dec; 32(12):814-8. PubMed ID: 22339953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imatinib in relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukaemia: a viewpoint by Ronan Swords.
    Swords R
    Drugs; 2007; 67(17):2655-6. PubMed ID: 18034599
    [No Abstract]   [Full Text] [Related]  

  • 31. Allogeneic Stem Cell Transplantation versus Tyrosine Kinase Inhibitors Combined with Chemotherapy in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.
    Wang J; Jiang Q; Xu LP; Zhang XH; Chen H; Qin YZ; Ruan GR; Jiang H; Jia JS; Zhao T; Liu KY; Jiang B; Huang XJ
    Biol Blood Marrow Transplant; 2018 Apr; 24(4):741-750. PubMed ID: 29247779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Philadelphia chromosome-positive acute lymphoblastic leukemia- current concepts and future perspectives.
    Faderl S; Garcia-Manero G; Thomas DA; Kantarjian HM
    Rev Clin Exp Hematol; 2002 Jun; 6(2):142-60; discussion 200-2. PubMed ID: 12196213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of cytogenetics, BCR-ABL PCR studies and fluorescence in situ hybridisation (FISH) in adult acute lymphoblastic leukaemia.
    Campbell LJ; Martinow A; Michael PM; White JS; Rayeroux KC; Januszewicz EH
    Aust N Z J Med; 1999 Oct; 29(5):707-12. PubMed ID: 10630652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adult Philadelphia-chromosome-positive acute lymphoblastic leukemia: experience of treatments during a ten-year period.
    Annino L; Ferrari A; Cedrone M; Giona F; Lo Coco F; Meloni G; Arcese W; Mandelli F
    Leukemia; 1994 Apr; 8(4):664-7. PubMed ID: 8152262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival in adult acute lymphoblastic leukaemia (ALL): A report from the Swedish ALL Registry.
    Lennmyr E; Karlsson K; Ahlberg L; Garelius H; Hulegårdh E; Izarra AS; Joelsson J; Kozlowski P; Moicean A; Tomaszewska-Toporska B; Lübking A; Hallböök H;
    Eur J Haematol; 2019 Aug; 103(2):88-98. PubMed ID: 31074910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blinatumomab compared with standard of care for the treatment of adult patients with relapsed/refractory Philadelphia chromosome-positive B-precursor acute lymphoblastic leukemia.
    Rambaldi A; Ribera JM; Kantarjian HM; Dombret H; Ottmann OG; Stein AS; Tuglus CA; Zhao X; Kim C; Martinelli G
    Cancer; 2020 Jan; 126(2):304-310. PubMed ID: 31626339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Computer aided analysis of additional chromosome aberrations in Philadelphia chromosome positive acute lymphoblastic leukaemia using a simplified computer readable cytogenetic notation.
    Bradtke J; Balz H; Fonatsch C; Heinze B; Jauch A; Mohr B; Schoch C; Rieder H
    BMC Bioinformatics; 2003 Jan; 4():4. PubMed ID: 12549981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical and laboratorial analysis for 15 adult cases of mixed phenotypic acute leukemia with Ph chromosome and/or positive BCR-ABL].
    Yan LZ; Chen SN; Ping NN; Wang QR; Liu H; Ding ZX; Zhu MQ; Liang JY; Liu DD; Cen JN; Pan JL; Qiu HY; Sun AN; Wu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1116-20. PubMed ID: 24156417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term follow-up of a phase 2 study of chemotherapy plus dasatinib for the initial treatment of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Ravandi F; O'Brien SM; Cortes JE; Thomas DM; Garris R; Faderl S; Burger JA; Rytting ME; Ferrajoli A; Wierda WG; Verstovsek S; Champlin R; Kebriaei P; McCue DA; Huang X; Jabbour E; Garcia-Manero G; Estrov Z; Kantarjian HM
    Cancer; 2015 Dec; 121(23):4158-64. PubMed ID: 26308885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Karyotype at diagnosis is the major prognostic factor predicting relapse-free survival for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with imatinib-combined chemotherapy.
    Yanada M; Takeuchi J; Sugiura I; Akiyama H; Usui N; Yagasaki F; Nishii K; Ueda Y; Takeuchi M; Miyawaki S; Maruta A; Narimatsu H; Miyazaki Y; Ohtake S; Jinnai I; Matsuo K; Naoe T; Ohno R;
    Haematologica; 2008 Feb; 93(2):287-90. PubMed ID: 18223280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.